Kunming, China

Lian Yang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jiuzhitang Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lian Yang. Retrieved from https://idiyas.com/inventor/lian-yang-52bya5uh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lian Yang: Innovator in Oligoglycosaminoglycan Research

Introduction

Lian Yang is a notable inventor based in Kunming, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oligoglycosaminoglycans. His innovative work focuses on creating compounds that can aid in the prevention and treatment of thrombotic diseases.

Latest Patents

Lian Yang holds a patent for a Fuc3S4S substituted oligoglycosaminoglycan and its preparation method. This invention involves a compound with a weight-average molecular weight (Mw) of about 4.5-9 kD. The patent also includes a pharmaceutical composition containing this oligoglycosaminoglycan, along with its preparation method and potential uses in medicine.

Career Highlights

Lian Yang is associated with Jiuzhitang Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on medical treatments, particularly in addressing thrombotic conditions.

Collaborations

Lian Yang collaborates with esteemed colleagues, including Jinhua Zhao and Jinxing He. Their combined expertise contributes to the innovative research being conducted at Jiuzhitang Co., Ltd.

Conclusion

Lian Yang's contributions to the field of oligoglycosaminoglycans highlight his role as a key innovator in pharmaceutical research. His patent and ongoing work promise to enhance medical treatments for thrombotic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…